metabolic heart disease 中文意思是什麼

metabolic heart disease 解釋
代謝性心臟病
  • metabolic : adj. 1. 變化的,變形的。2. 【生物學】新陳代謝的,代謝作用的。
  • heart : n 1 心臟,心。2 胸,胸部;心胸,心地,心腸,胸懷。3 感情,熱情,愛情;靈魂;良心。4 勇氣,膽力;...
  • disease : n. 1. 病,疾病;【植物;植物學】病害。2. (精神等的)病態,弊病。3. (酒等的)變質;(食物等的)腐敗。4. 〈廢語〉不安。
  1. 1 alexander cm , landsman pb , teutsch sm , et al. ncep defined metabolic syndrome diabetes and prevalence of coronary heart disease among nhanes iii participants age 50 years and order. diabetes , 2003 , 52 ( 5 ) : 1210

    2中華醫學會糖尿病學分會代謝綜合征研究協作組.中華醫學會糖尿病學分會關于代謝綜合征的建議.中華醫學會糖尿病雜志, 2004 , 12 ( 3 ) : 156 - 160
  2. Among patients with the metabolic syndrome ( 7, 327 black and 15, 750 white patients ), the calcium channel blocker, ace inhibitor and alpha - blocker had higher rates of heart failure compared with the diuretic ; the ace inhibitor and the alpha - blocker also had an increased risk of combined cardiovascular disease

    在合併代謝綜合徵人群(黑種人7327名白種人15750名)中,鈣通道阻滯劑、血管緊張素轉換酶抑制劑-阻滯劑治療組較利尿劑治療組有更高的心衰發病率; -阻滯劑治療組、血管緊張素轉換酶抑制劑治療組也有並發心血管疾病的危險性增高。
  3. In the april s issue arteriosclerosis thrombosis and vascular biology, published by the american heart association, professor woo found that in 228 healthy subjects who have neither heart disease or diabetes but with " high normal " glycemia levels ( or with a number of components of metabolic syndrome ), carotid intima - media thickening, an important marker for arteriosclerosis, was observed

    胡教授在《動脈硬化、栓塞和血管生物雜志》 ( arteriosclerosis , thrombosis , vascularbiology )的文章中指出:在228位尚未發現有心血管疾病亦未診斷為糖尿病患者的健康人中,血糖水平在正常界域但稍偏高(或兼有某些代謝綜合癥) ,其頸動脈內中膜厚度比其他正常人增厚,這是血管硬化病變的一個重要標示。
  4. Correlation of myocyte enhancer factor 2a mutation and the liability to coronary heart disease in patients with metabolic syndrome

    代謝綜合征患者心肌細胞增強因子基因突變與易發冠狀動脈粥樣硬化性心臟病的關系
  5. Researchers may be able to apply that knowledge to improve understanding of what causes the body ' s metabolic machinery to malfunction in the more “ garden variety ” forms of heart disease

    研究人員也許能夠運用這些知識改善理解是什麼導致軀體代謝機制在心臟病的更多「普通的」類型中功能失調。
  6. “ no differences were noted among the four treatment groups, regardless of race or metabolic syndrome status for the primary end point ( non - fatal myocardial infarction [ heart attack ] and fatal coronary heart disease ), ” the authors write

    「不考慮種族或代謝綜合征具體情況,主要終點(非致命性心肌梗塞[心臟病發作]致命性冠心病)上四個治療組沒有區別, 」作者寫道。
分享友人